Cantor Fitzgerald Initiates Coverage On ArriVent BioPharma with Overweight Rating
Benzinga Newsdesk 10 months ago
NewsInitiationAnalyst Ratings
Cantor Fitzgerald analyst Li Watsek initiates coverage on ArriVent BioPharma (NASDAQ:AVBP) with a Overweight rating.
Cantor Fitzgerald analyst Li Watsek initiates coverage on ArriVent BioPharma (NASDAQ:AVBP) with a Overweight rating.